Navigation Links
Dr. Oz, Host Of The Dr. Oz Show, and Harry Zhabilov Of Immunotech Laboratories Discuss Immunotherapy Treatments For Cancer, HIV/AIDS
Date:2/6/2013

HUNTINGTON BEACH, Calif., Feb. 6, 2013 /PRNewswire/ -- Recently www.UndiscoveredCompanies.com was able to ask Dr. Mehmet Oz , host of the Dr. Oz show and Harry Zhabilov, President of Immunotech Laboratories (PINKSHEETS:IMMB) about Immunotherapy Treatments and how they are used to treat patients suffering with Cancer, and HIV/AIDS Virus.

Dr. Oz demonstrates an amazing wealth of knowledge in Immunotherapy.  The Doctor is not only charismatic, but also articulates his incredible knowledge about the treatment thoroughly.  Dr. Otis Brawley from the American Cancer Society also added some unique advancement comments about Immunotherapy Treatments.

Please view the video featuring Harry Zhabilov, Dr. Oz, and Dr. Otis Brawley at the following YouTube link. http://youtu.be/D0SvkO_jMK4

Review video testimonials of now symptom free Cancer and HIV patients treated with Immunotech's IPF Technology at http://www.lifechoicemx.com

About Immunotech Laboratories
Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases suck as HIV, Cancer, Hepatitis and Aids. Immunotech is committed to creating drugs for the better health of mankind.

About Undiscovered Companies
Undiscovered Companies is a video news provider of public and private companies looking for new marketing ideas and product exposure.  Subscribe at http://undiscoveredcompanies.com for free.

Safe Harbor Statement: This release may include the use of forward-looking statements intended to qualify for the safe harbor from liability established by
'/>"/>

SOURCE Immunotech Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures
2. Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines
3. Nelson Laboratories to Host Free Educational Device Testing Classes at 2013 MD&M West Show
4. Charleston Laboratories, Inc. Begins Enrollment for CL-108 Phase 3 Clinical Trial
5. Charleston Laboratories, Inc. beginnt mit klinischer Phase 3-Studie für CL-108
6. Heraeus Named "Supplier of the Year" by National Association of Dental Laboratories
7. New Jensen Dental White Paper Reveals How Dental Laboratories Can Increase Productivity, Profitability with a Multi-Function Pressing Furnace
8. AAIPharma Announces Promotion Of Dean Shirazi To EVP Of Analytical Laboratories
9. IDEXX Laboratories Announces Entry Into Consent Agreement with FTC Bureau of Competition Staff
10. Abuse Deterrent Medicines Developer Pisgah Laboratories, Inc. Wins Top 5 Technologies Award from CLAAD
11. Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb the ... ambulances and other transport vehicles, an advanced and portable UV germicidal ... for the first time. In order to prevent ... deadly pathogens, West Palm Beach Fire Rescue ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that ... available in its catalogue: ... for Advanced Drug Delivery Systems -- ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
(Date:4/23/2014)... the depletion of self-control, according to research published in ... for Psychological Science. , Self-control can be difficult ... on a boring textbook are hard things to do. ... Exerting self-control for a long period seems to "deplete" ... , "It is as if self-control is a limited ...
(Date:4/22/2014)... industry leaders visited the New Jersey Institute of ... S. Bloom for the launch of the New ... provides a new model for business innovation through ... assets and investment. U.S. Senator Cory Booker, Panasonic ... Taylor, New Jersey Lieutenant Governor Kim Guadagno, New ...
(Date:4/22/2014)... at UT Southwestern Medical Center are making breakthroughs that ... A team of physician-scientists at UT Southwestern has ... with natural anti-depressant properties) works inside the brain. Simultaneously, ... depression in the form of a neuroprotective drug known ... in April,s issue of Molecular Psychiatry, is ...
(Date:4/22/2014)... Washington, DC (April 22, 2014) The International ... May 22-26 in Seattle, Washington. The theme of ... life" means in a networked and digital society. ... and attended by over 2,200 Communication scholars representing ... largest scholarly international communication conference in the world. ...
(Date:4/22/2014)... latest scientific advances and emerging therapies in heart failure ... annual meeting of the Heart Failure Association (HFA) of ... hear breaking news on acute heart failure during the ... part of the main congress. , The event will ... Megaron Athens International Conference Centre (MAICC). The full scientific ...
Breaking Medicine News(10 mins):Health News:ADHD drug may help preserve our self-control resources 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 3Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2Health News:The world's largest heart failure congress 2Health News:The world's largest heart failure congress 3
... gender and weight, play role in infant,s chances, study ... When it comes to the survival of premature infants, ... gestational age, but a new study suggests that gestational ... and parents should consider when deciding what treatment, if ...
... -- Lotus,Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) (,Lotus, or ... China,("PRC"), today announced financial results for the fourth quarter ... Quarter 2007 Highlights -- Total revenues increased to ... quarter of 2006 -- Gross profit ...
... April 17 ProGenTech, a life,sciences company based ... to,announce that it has made several executive management ... Dr. Paul Richardson has joined ProGenTech as ... Dr. Richardson will lead the global R&D programs,and ...
... CRM Holdings,Ltd. ("the Company") (Nasdaq: CRMH ) ... wholly-owned subsidiary of the Company, has,received notice from ... following an initial investigation, the WCB has determined ... CRM,s third party,administrator,s license to provide third party ...
... 16 The California Nurses,Association,s (CNA) insistence on presenting ... the Service Employees International,Union (SEIU) reached new levels this ... admit photos it claimed as evidence of,"violence by protesters" ... images of SEIU staff and members injured by conference ...
... Consumer,Watchdog today joined L.A. City Attorney Rocky Delgadillo ... Blue Cross engaged in unfair,business practices by illegally ... sick., The practice -- known as "rescission" ... have been left uninsured, uninsurable, and facing up ...
Cached Medicine News:Health News:Gestational Age Not Sole Predictor of Preemie Survival 2Health News:Gestational Age Not Sole Predictor of Preemie Survival 3Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 2Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 3Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 4Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 5Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 6Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 7Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 8Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 9Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 10Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 11Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 12Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 13Health News:Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results 14Health News:ProGenTech Limited Appoints Executive Management Team 2Health News:Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers' Compensation Board 2Health News:Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers' Compensation Board 3Health News:Consumer Watchdog Applauds L.A. City Attorney's Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Immediately Reinstate Coverage 2
... solid made, manual plate washer for ... dispense and aspirate function ensure proper ... a stand and all necessary tubings. ... as well as any bottles for ...
... MP-1200 is a compact and simple ... internal micropumps enable the system both ... all types of microtiter well. MW-1200 ... in rows of 8 wells or ...
High precision microplate washer for immuno and adherent cell assays. For use with all strip types and full microplate in 96- and 384-well format in both portrait and landscape orientations....
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use....
Medicine Products: